Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Adamas Pharmaceuticals, Inc.

NASDAQ: ADMSHealthcare / Drugs - Generic / USA
10.99-0.2500-2.22%Vol 483 5511Y Perf -59.76%
Feb 21st, 2019 16:00
BID10.40 ASK11.45
Open11.27 Previous Close11.24
Pre-Market- After-Trading10.99
 - -%  - -%
Target Price
32.38 
Analyst Rating
Strong Buy 1.50
Potencial %
194.63 
Finscreener Ranking
★★★ —    -
Insiders Trans % 3/6/12M
-100/-50/-83 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/15/-83 
Growth Ranking
★★+     48.44
Insiders Shares Cnt. % 3/6/12M
-100/25/-70 
Income Ranking
 —    -
Market Cap (mil)300 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
14.01 
Earnings Date
28th Feb 2019

Today's Price Range

10.8111.78

 

52wk Range

7.4232.90

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
26.76%
3 Months
4.57%
6 Months
-50.20%
1 Year
-59.76%
3 Years
-25.54%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ADMS10.99-0.2500-2.22
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.60
Current Ratio
8.90
Long Term Debt to Total Capital
0.50
Total Debt to Equity
1.01
Interest Coverage
-6.60
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
99.00
EBIT Margin
-542.70
EBITDA Margin
-536.10
Pre-tax Profit Margin
-9 083.60
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.17
PS Ratios
13.08
Price to Cash Flow
23.20
Price to Free Cash Flow
-3.00
Cash Flow Per Share
-4.09
Price to Tangible Book
2.17
Book Value per Share
4.18
Enterprise Value (in ths.)
152 093
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-31.75
ROE last 12 Months
-131.87
Return on Assets (5Y Avg)
-15.96
ROA last 12 Months
-66.94
Return on Capital (5Y Avg)
-33.26
ROC last 12 Months
-66.72
Return on invested Capital Q
-11.89
Return on invested Capital Y
-42.74
Assets Turnover
0.10
Receivables Turnover
6.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
20 731
Revenue per Share
0.76
Revenue Growth 3 Years
55.00
Revenue Growth 5 Years
-51.29
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.34-1.228.96
Q02 2018-1.41-1.2610.64
Q01 2018-1.38-1.352.17
Q04 2017-1.15-1.27-10.43
Q03 2017-1.03-1.04-0.97
Q02 2017-0.85-0.93-9.41
Q01 2017-0.72-0.720.00
Q04 2016-0.82-0.6817.07
Earnings Per EndEstimateRevision %Trend
12/2018 QR-1.362.16Positive
12/2018 FY-5.210.38Positive
3/2019 QR-1.200.00-
12/2019 FY-4.15-7.24Negative
Next Report Date28th Feb 2019
Estimated EPS Next Report-1.36
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume483 551
Shares Outstanding (in ths.)27 336
Trades Count2 178
Dollar Volume4 743 417
Avg. Volume469 792
Avg. Weekly Volume570 763
Avg. Monthly Volume480 476
Avg. Quarterly Volume534 669

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

47%53%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (75.00 %)
6 (75.00 %)
6 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (25.00 %)
2 (25.00 %)
2 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

There are no comments yet.

News